Cytokinetics, Incorporated

About Cytokinetics, Incorporated

Cytokinetics, Incorporated is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases. Its pipeline targets diseases like amyotrophic lateral sclerosis, chronic heart failure, hypertrophic cardiomyopathy, and spinal muscular atrophy. The company leverages its expertise in muscle biology and contractility to advance small-molecule drug candidates that modulate muscle function, aiming to improve patient outcomes in areas with significant unmet medical need.